Page 10 - முதலீட்டாளர் சந்திக்க நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Investegate |Reach PLC Announcements | Reach PLC: Investor Presentation on Investor Meet Platform
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
UK: Orcadian Energy provides Pilot field development update ahead of investor presentation
energy-pedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from energy-pedia.com Daily Mail and Mail on Sunday newspapers.
Investegate |Shearwater Group PLC Announcements | Shearwater Group PLC: Notice of Results and Presentation to Investors
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Proactive news headlines: Induction Healthcare PLC, Corero Network Security PLC, One Media iP Group PLC, Alliance Pharma PLC
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Anna Dunphy / Paul McManus / Louis Ashe-Jepson GENinCode plc is engaged in the risk assessment, prediction and prevention of cardiovascular disease ( CVD ). CVD is the leading cause of death worldwide accounting for approximately 18 million deaths annually. The Company s products and technology have been developed with the aim of predicting the onset of CVD and providing a personalised treatment pathway for patient management. Its products have been the subject of clinical studies on over 75,000 patients to assess and predict the onset of CVD. The Company was incorporated in September 2018 to acquire the assets, intellectual property and know-how of the Ferrer inCode and Gendiag.exe businesses, which were then part of Grupo Ferrer Internacional S.A., a large Spanish multinational private pharmaceutical and healthcare company. The technology and products acquired included Cardio inCode®, Lipid inCode®, Thrombo inCode® and Sud